Cecilia Jädert
Direttore/Membro del Consiglio presso Strominnate Therapeutics AB
Posizioni attive di Cecilia Jädert
Società | Posizione | Inizio | Fine |
---|---|---|---|
Strominnate Therapeutics AB
Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Cecilia Jädert
Statistiche
Distribuzione geografica
Svezia | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Strominnate Therapeutics AB
Strominnate Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Strominnate Therapeutics AB is a Swedish company that offers effective treatments for tumors and conditions of the nervous system. The company is based in Lund, Sweden. The company was founded in 2021 by Tania Ramos Moreno, who is also the CEO of the company and a guest researcher at the Stem Cell Center in Lund University. The company provides a new product as a novel therapy for treating Glioblastoma multiforme, the most common and malignant brain tumor in adults. The product contains the antitumoral components and the environment modulators produced by a recently discovered human immune cell. | Commercial Services |
- Borsa valori
- Insiders
- Cecilia Jädert
- Esperienza